LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Independent Market Research Ranks Sysmex in Hematology Instruments

By LabMedica International staff writers
Posted on 17 Mar 2009
In IMV's 2008 ServiceTrak annual report Sysmex America (Mundelein, IL, USA) was ranked best in hematology instrument reliability and industry for the ninth consecutive year. Sysmex also ranked first in 21 of the 30 survey factors, including all five Original Equipment Manufacturer (OEM) service performance factors and all five manufacturer and instrument performance factors. The IMV ServiceTrak survey respondents include clinical laboratory department supervisors, laboratory managers, and technologists chosen at random from hospitals of varying sizes from across the country.

For customer satisfaction, Sysmex hematology instruments also ranked first in MD Buyline's January 2009 User Satisfaction Ratings. MD Buyline survey respondents include technologists and clinicians from hospitals and clinical reference laboratories located throughout the United States. MD Buyline is a comprehensive database of information on healthcare products.

"Regardless of the healthcare industry's economic concerns, we know our customers must provide high quality care for their patients. As a healthcare partner to many of the nation's healthcare facilities, we are honored that our hematology instruments have met their needs in reliability and performance expectations," said John Kershaw, president, Sysmex America, Inc.

Instrument reliability also impacts clinical laboratory performance metrics such as results turnaround time and repeat rate. Switching to backup analyzers could create issues with shifting normal ranges and consistency of results used in patient trending analysis. "Therefore, clinical laboratories will want to assess their instrument capability relative to their effect on service lines, care pathways, medical errors, and patient flow," added Mr. Kershaw.

Sysmex America, Inc., the U.S. headquarters of Sysmex Corporation (Kobe, Japan), distributes and supports automated in vitro diagnostic hematology, coagulation, and urinalysis analyzers, reagents, and information systems for laboratories and healthcare facilities throughout the Western Hemisphere. The company focuses on extending the boundaries of diagnostic science while providing the management information tools that make a real difference in clinical and operational results for people worldwide.

Related Links:

Sysmex America


Gold Member
Fibrinolysis Assay
HemosIL Fibrinolysis Assay Panel
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Hemodynamic System Monitor
OptoMonitor
CBM Analyzer
Complete Blood Morphology (CBM) Analyzer

Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more